These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3354733)

  • 41. Estrogen replacement after menopause. When is it warranted?
    Charles AG
    Postgrad Med; 1989 Mar; 85(4):99-101, 104. PubMed ID: 2928282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogen with and without progestin: benefits and risks of short-term use.
    LaCroix AZ
    Am J Med; 2005 Dec; 118 Suppl 12B():79-87. PubMed ID: 16414331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
    Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
    Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen plus a progestin for prevention of postmenopausal osteoporosis.
    Med Lett Drugs Ther; 1985 Oct; 27(699):91-2. PubMed ID: 3903458
    [No Abstract]   [Full Text] [Related]  

  • 46. The risk of breast cancer after estrogen and estrogen-progestin replacement.
    Bergkvist L; Adami HO; Persson I; Hoover R; Schairer C
    N Engl J Med; 1989 Aug; 321(5):293-7. PubMed ID: 2546079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estrogen plus progestin in postmenopausal women--act II.
    MacDonald PC
    N Engl J Med; 1986 Oct; 315(15):959-61. PubMed ID: 3762597
    [No Abstract]   [Full Text] [Related]  

  • 48. Can we measure prior postmenopausal estrogen/progestin use? The Postmenopausal Estrogen/Progestin Interventions Trial. The PEPI Investigators.
    Greendale GA; James MK; Espeland MA; Barrett-Connor E
    Am J Epidemiol; 1997 Nov; 146(9):763-70. PubMed ID: 9366624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer and the use of estrogens.
    Gambrell RD
    Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.
    Rossi R; Bursi F; Veronesi B; Cagnacci A; Modena MG
    Maturitas; 2004 Dec; 49(4):315-20. PubMed ID: 15531127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estrogen plus progestin versus estrogen after definitive surgery for endometriosis: a study of pain recurrence.
    Cheewadhanaraks S; Choksuchat C; Wattanakumtornkul S
    J Med Assoc Thai; 2013 Aug; 96(8):881-7. PubMed ID: 23991592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Which estrogens and gestagens should be prescribed after 45 years of age and for how long?].
    Göretzlehner G
    Zentralbl Gynakol; 1990; 112(13):793-4. PubMed ID: 2238980
    [No Abstract]   [Full Text] [Related]  

  • 53. Hormone replacement therapy around and after the menopause: when and how?
    Drug Ther Bull; 1987 May; 25(9):33-6. PubMed ID: 3582181
    [No Abstract]   [Full Text] [Related]  

  • 54. Estrogen replacement therapy in patients with endometrial cancer: prescription attitude of Belgian gynecologists.
    Rozenberg S; Vasquez JB
    Maturitas; 2000 May; 35(2):125-8. PubMed ID: 10924838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
    Topal NB; Ayhan S; Topal U; Bilgin T
    J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimal use of postmenopausal hormone replacement.
    Ettinger B
    Obstet Gynecol; 1988 Nov; 72(5 Suppl):31S-36S. PubMed ID: 3173939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre.
    Cano A
    Maturitas; 1994 Dec; 20(2-3):91-9. PubMed ID: 7715479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Estrogen metabolism and hormone substitution in the climacteric].
    Göretzlehner G; Kyank H
    Zentralbl Gynakol; 1985; 107(16):977-88. PubMed ID: 2996259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.